Savvy Psychopharmacology

Smoking cessation: What to tell patients about over-the-counter treatments

Author and Disclosure Information

 

References

Disclosure

Dr. Ellingrod receives grant/research support from the National Institute of Mental Health.

Dr. Burghardt reports no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.

Table 2

Prescription smoking cessation productsa

ProductDosageSide effectsAmount of nicotineCostbNotes
Nicotine inhaler6 to 16 cartridges/dThroat/mouth irritation and cough10 mg cartridges deliver 4 mg of nicotine10 mg inhaler with 168 cartridges: $213Vapor, not smoke, is released and deposited in mouth. Similar mechanism of action to nicotine gum. Continuously puff for ~20 minutes. Gradually reduce dosage over 12 weeks. Helps with patients who need the “action” of smoking. Caution in patients who have a history of bronchospastic disease because of potential airway irritation
Nicotine nasal spray10 mg/ml bottle
8 to 40 doses/d One dose is a spray to each nostril
Initial (~10 week) watery eyes, coughing, and nasal and throat irritation0.5 mg/spray10 ml bottle: $186Fastest delivery of nicotine vs other products. Tilt head back slightly when delivering spray. Do not sniff, swallow, or inhale through the nose. Continue treatment for 3 to 6 months with an individualized reduction in usage
Bupropion SR150 mg/d for 3 days, then 300 mg/d for 7 to 12 weeks or longerWeight change, constipation, confusion, headache, and insomniaN/A60 tablets: $106Patients should stop smoking during the second week of treatment. Combination treatment has achieved higher cessation rates. Avoid bedtime dosing to minimize insomnia (eg, 7 AM and 3 PM dosing strategy). Avoid in patients with seizure disorders
VareniclineDays 1 to 3: 0.5 mg/d
Days 4 to 7: 1 mg/d
Day 8 to end of treatment: 2 mg/d
Start treatment 1 week before quitting and continue for 3 to 6 months
Constipation, flatulence, nausea, vomiting, insomnia, and headacheN/AStarting pack: $179
Continuing pack: $177
Partial agonist of nicotinic acetylcholine receptor. Superiority to placebo has been shown but more studies are needed to show superiority to NRT. Safety and efficacy of combination therapy has not been established. Pack titrates dosage to 2 mg/d to decrease nausea. Take with water and food. Has a “black-box” warning for serious neuropsychiatric events, including suicidal ideations and behavior

Pages

Next Article: